Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Jiangsu Huigao Pharmaceutical Co., Ltd. is a Chinese pharmaceutical company founded in 2021 and based in Suining County, Xuzhou City, Jiangsu Province. The company specializes in the research, development, manufacturing, and sales of pharmaceuticals, medical devices, and health foods, with a particular focus on pediatric specialty drugs. Its flagship commercial product is Lysine Inositol Vitamin B12 Oral Solution, which is widely used to treat loss of appetite, nutritional deficiencies, and growth retardation in infants, children, and adolescents. Jiangsu Huigao operates a modern manufacturing facility designed to meet GMP standards, featuring automated production lines with an annual capacity of up to 100 million bottles.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Jiangsu Huigao Pharmaceutical.